Cardiovascular CRO Services
Take advantage of InnoSer’s cardiovascular expertise and portfolio spanning gold-standard surgical and induced models of common cardiovascular diseases
Preclinical Cardio-metabolic Research with InnoSer
✓ Cardiac Surgery In-house
✓ Smart Pathological Assessments
✓ Powerful Imaging Techniques
✓ Fast Study Initiation
✓ Tailored Study Designs
✓ Dedicated Research Co-oridnators
As a European preclinical cardiovascular contract research organization (CRO), InnoSer offers you a portfolio of gold-standard mouse models of common cardiovascular diseases and heart failure (with models of both HFrEF and HFpEF). By leveraging our expertise in cardiovascular disease modeling together with our specialized facilities and trained personnel equipped for reliable execution of technical cardiac surgeries and other technical imaging and functional procedures, InnoSer ensures you obtain robust data while ensuring flexible study start-up times.
Choosing InnoSer as your cardiovascular CRO services research partner allows you to combine both disease model expertise with pharmacology, providing valuable insight into mechanism of action (MoA), pharmacokinetics/ pharmacodynamics (PK/PD profiling) and early-stage toxicity of your lead compounds. InnoSer’s cardiovascular study experts possess relevant experience in working with multiple therapy types ranging from small molecules, biologics to (stem) cell therapy approaches for multiple cardiovascular indications. InnoSer’s study expert team works with you to confidently demonstrate the safety and efficacy profile of your novel investigational compound.
Preclinical Cardiovascular Model Catalogue
Angiotensin II-induced Hypertension Mouse Model
Transverse Aortic Constriction (TAC) Mouse Model of Heart Failure
Diabetic Cardiomyopathy Rat Model
Don’t See Your Model? We Can Help!
Our experts specialize in tailored solutions to meet your unique research needs. Let’s discuss how we can support your project.
Cardio-Metabolic Research with InnoSer
Powered by imaging capabilities
Particularly in vivo imaging has become a valuable tool for collecting mid-study data in animal studies. These non-invasive methods can be applied with high sensitivity and in real-time. With InnoSer’s imaging capabilities measure a variety of functional cardiac readouts customizeable to your research outcomes. These readouts can include cardiac function, infarct size, heart tissue mass, and ejection fraction.
Smart pathological assessment
Enhance the translational value of your cardio-metabolic research with a histopathological assessment of clinically relevant biomarkers. We can provide insights into inflammation, vascularization, hypertrophy and fibrosis using sound techniques and expert application. Supported by digital workflows for efficient and accurate results our histopathology services will see your research enhanced through technology. Read more >>
Fast study initiation with timely and insightful updates
Our cardio-metabolic models are initiated quickly and set up upon agreement with our dedicated cardio-metabolic study team. Timely updates enable you to closely follow the progression of your project and help inform and guide your research. We provide consulting on relevant endpoint analysis and help guide and inform your research with our expertise.
Your Cardio-metabolic Research Starts Here.
Download our cardio-metabolic leaflet and compare the model capabilities
Stay Curious: More Articles to Explore
Project Completion Announcement: CARDIOIDS Collaboration with Professor Leon de Windt Advances Arrhythmogenic Cardiomyopathy (ACM) Research
In its role as an industry research partner, InnoSer is pleased to announce the successful completion of the CARDIOIDS project, a consortium-led initiative led by Professor Leon de Windt at Maastricht University. This project represents a major milestone in...
Latest cardiovascular and metabolic research news
InnoSer offers a selection of gold standard cardio-metabolic disease models in rodents, supporting custom studies to optimize the preclinical development of your drug candidates. Learn more about you can leverage InnoSer’s experience and expertise in the cardio and...
AAALAC Accreditation
InnoSer has earned the AAALAC accreditation, demonstrating our commitment to responsible animal care and use. AAALAC International is a nonprofit organization that promotes the humane treatment of animals in science through voluntary accreditation and assessment programs. Our accreditation is valid for three years, incl. 2023. Read more about the AAALAC accreditation programme here.
Animal Welfare
The 3Rs impact everything from policy and regulatory change to the development and uptake of new technologies and approaches. This is why InnoSer has ongoing commitment and monitoring of these processes. The steps we practice maximize our ability to replace, reduce and refine animal involvement and facilitate our commitment to these principles when it comes to research and drug development.
info@innoserlaboratories.com